Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: GeneDx Holdings Corp., 3 years.
GeneDx Holdings Corp.
Director
Standard BioTools Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Standard BioTools Inc. June 17, 202694.0%
-
Standard BioTools Inc. June 14, 2023100.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Standard BioTools Inc. | Grant or award | +99,116 | — | — |
| Jun 18, 2026 | GeneDx Holdings Corp. | Option exercise | +3,576 | — | — |
| Jun 5, 2026 | GeneDx Holdings Corp. | Open-market purchase | +50,000 | $52.86 | $2,643,000 |
| Jun 4, 2026 | GeneDx Holdings Corp. | Open-market purchase | +150,000 | $56.44 | $8,466,000 |
| Feb 26, 2026 | Standard BioTools Inc. | Grant or award | +52,991 | $1.17 | $61,999 |
| Nov 20, 2025 | Standard BioTools Inc. | Open-market purchase | +450,000 | $1.30 | $585,000 |
| Nov 19, 2025 | Standard BioTools Inc. | Open-market purchase | +350,000 | $1.28 | $448,000 |
| Nov 18, 2025 | Standard BioTools Inc. | Open-market purchase | +275,000 | $1.23 | $338,250 |
| Sep 4, 2025 | Standard BioTools Inc. | Open-market purchase | +250,000 | $1.28 | $320,000 |
| Sep 3, 2025 | Standard BioTools Inc. | Open-market purchase | +250,000 | $1.27 | $317,500 |
| Aug 22, 2025 | GeneDx Holdings Corp. | Open-market sale | −500,000 | $120.90 | $60,450,000 |
| Aug 15, 2025 | Standard BioTools Inc. | Open-market purchase | +150,000 | $1.22 | $183,000 |
| Aug 14, 2025 | Standard BioTools Inc. | Open-market purchase | +133,220 | $1.21 | $161,196 |
| Aug 13, 2025 | Standard BioTools Inc. | Open-market purchase | +75,000 | $1.31 | $98,250 |
| Aug 11, 2025 | BioLife Solutions Inc. | Open-market sale | −500,000 | $22.60 | $11,300,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.